Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Hepatitis C virus: a new class of virus associated with particles derived from very low-density lipoproteins.

Ye J.

Arterioscler Thromb Vasc Biol. 2012 May;32(5):1099-103. doi: 10.1161/ATVBAHA.111.241448. Review.

2.

Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

Jammart B, Michelet M, Pécheur EI, Parent R, Bartosch B, Zoulim F, Durantel D.

J Virol. 2013 May;87(9):5065-80. doi: 10.1128/JVI.01405-12.

3.

Apolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C Virus.

Gondar V, Molina-Jiménez F, Hishiki T, García-Buey L, Koutsoudakis G, Shimotohno K, Benedicto I, Majano PL.

J Virol. 2015 Oct;89(19):9962-73. doi: 10.1128/JVI.00577-15.

4.

Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.

Sun HY, Lin CC, Lee JC, Wang SW, Cheng PN, Wu IC, Chang TT, Lai MD, Shieh DB, Young KC.

Gut. 2013 Aug;62(8):1193-203. doi: 10.1136/gutjnl-2011-301798.

PMID:
22689516
5.

Characterization of hepatitis C RNA-containing particles from human liver by density and size.

Nielsen SU, Bassendine MF, Martin C, Lowther D, Purcell PJ, King BJ, Neely D, Toms GL.

J Gen Virol. 2008 Oct;89(Pt 10):2507-17. doi: 10.1099/vir.0.2008/000083-0.

6.

Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.

Blaising J, Pécheur EI.

Biochimie. 2013 Jan;95(1):96-102. doi: 10.1016/j.biochi.2012.07.016. Review.

PMID:
22884392
7.

Hepatitis C virus relies on lipoproteins for its life cycle.

Grassi G, Di Caprio G, Fimia GM, Ippolito G, Tripodi M, Alonzi T.

World J Gastroenterol. 2016 Feb 14;22(6):1953-65. doi: 10.3748/wjg.v22.i6.1953. Review.

8.

Very low density lipoprotein and low density lipoprotein isolated from patients with hepatitis C infection induce altered cellular lipid metabolism.

Napolitano M, Giuliani A, Alonzi T, Mancone C, D'Offizi G, Tripodi M, Bravo E.

J Med Virol. 2007 Mar;79(3):254-8.

PMID:
17245726
9.

Hepatitis C virus hijacks host lipid metabolism.

Syed GH, Amako Y, Siddiqui A.

Trends Endocrinol Metab. 2010 Jan;21(1):33-40. doi: 10.1016/j.tem.2009.07.005. Review.

10.

Hepatitis C virus utilizes VLDLR as a novel entry pathway.

Ujino S, Nishitsuji H, Hishiki T, Sugiyama K, Takaku H, Shimotohno K.

Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):188-93. doi: 10.1073/pnas.1506524113. Erratum in: Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):188.

11.

Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.

Burlone ME, Budkowska A.

J Gen Virol. 2009 May;90(Pt 5):1055-70. doi: 10.1099/vir.0.008300-0. Review.

PMID:
19264629
12.

Hepatitis C virus and lipid droplets: finding a niche.

Filipe A, McLauchlan J.

Trends Mol Med. 2015 Jan;21(1):34-42. doi: 10.1016/j.molmed.2014.11.003. Review.

PMID:
25496657
13.

Primary hepatocytes as targets for hepatitis C virus replication.

Farquhar MJ, McKeating JA.

J Viral Hepat. 2008 Dec;15(12):849-54. doi: 10.1111/j.1365-2893.2008.01051.x. Review.

14.

Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins.

Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M Jr, Ye J.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5848-53.

15.

Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.

André P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, Pol S, Bréchot C, Paranhos-Baccalà G, Lotteau V.

J Virol. 2002 Jul;76(14):6919-28.

16.

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.

Bocchetta S, Maillard P, Yamamoto M, Gondeau C, Douam F, Lebreton S, Lagaye S, Pol S, Helle F, Plengpanich W, Guérin M, Bourgine M, Michel ML, Lavillette D, Roingeard P, le Goff W, Budkowska A.

PLoS One. 2014 Mar 19;9(3):e92140. doi: 10.1371/journal.pone.0092140.

17.

Lipids and HCV.

Bassendine MF, Sheridan DA, Bridge SH, Felmlee DJ, Neely RD.

Semin Immunopathol. 2013 Jan;35(1):87-100. doi: 10.1007/s00281-012-0356-2. Review.

PMID:
23111699
18.

Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model.

Calattini S, Fusil F, Mancip J, Dao Thi VL, Granier C, Gadot N, Scoazec JY, Zeisel MB, Baumert TF, Lavillette D, Dreux M, Cosset FL.

J Biol Chem. 2015 Sep 18;290(38):23173-87. doi: 10.1074/jbc.M115.662999.

19.

The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection.

Tao J, Kang KD, Hall SD, Laube AH, Liu J, Renfrow MB, Novak J, Luo G.

J Virol. 2015 Jul;89(13):6782-91. doi: 10.1128/JVI.00194-15.

20.

Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.

Felmlee DJ, Hafirassou ML, Lefevre M, Baumert TF, Schuster C.

Viruses. 2013 May 23;5(5):1292-324. doi: 10.3390/v5051292. Review.

Supplemental Content

Support Center